Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Form 8.3 - Centaur Media Plc

25 Sep 2013 14:22

RNS Number : 8976O
State Street Global Advisors
25 September 2013
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

 

State Street Global Advisors & Affiliates

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Centaur Media Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

24-September-2013

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,692,514

1.18449

(2) Derivatives (other than options): CFD

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,692,514

1.18449

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

 

 (b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

No

 

 

Date of disclosure:

 

25-September-2013

Contact name:

 

Chetan Shah

Telephone number:

 

020 3395 6564

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETZMGZLFKGGFZM
Date   Source Headline
21st Apr 20268:00 amRNSCancellation - Centaur Media PLC
20th Apr 20265:52 pmRNSHolding(s) in Company
16th Apr 20269:41 amRNSHolding(s) in Company
16th Apr 20269:39 amRNSHolding(s) in Company
16th Apr 20269:37 amRNSHolding(s) in Company
16th Apr 20269:36 amRNSHolding(s) in Company
7th Apr 20265:45 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:52 pmRNSHolding(s) in Company
1st Apr 20264:41 pmRNSHolding(s) in Company
31st Mar 20264:23 pmRNSHolding(s) in Company
31st Mar 202611:15 amRNSHolding(s) in Company
30th Mar 20264:44 pmRNSHolding(s) in Company
30th Mar 202611:19 amRNSHolding(s) in Company
30th Mar 202611:06 amRNSHolding(s) in Company
27th Mar 20262:30 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSResult of Tender Offer
23rd Mar 202612:08 pmRNSUpdate on Tender Offer
17th Mar 20261:25 pmRNSResult of Court Hearing
26th Feb 20267:00 amRNSResult of General Meeting
18th Feb 20267:00 amRNSStrategic Partnership
10th Feb 20262:44 pmRNSHolding(s) in Company
5th Feb 20263:59 pmRNSHolding(s) in Company
4th Feb 202611:24 amRNSHolding(s) in Company
30th Jan 20267:00 amRNSTender Offer
6th Jan 20267:00 amRNSTender offer update and sale of Econsultancy
24th Nov 202510:57 amRNSChange of Registered Office
29th Oct 20258:28 amRNSUpdate on Return of Capital
22nd Oct 20254:14 pmRNSHolding(s) in Company
22nd Oct 202512:03 pmRNSHolding(s) in Company
21st Oct 20254:39 pmRNSHolding(s) in Company
21st Oct 20252:12 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSDirector/PDMR Shareholding
9th Oct 20255:15 pmRNSDirector/PDMR Shareholding
8th Oct 20252:00 pmRNSSale of The Lawyer
25th Sep 20257:00 amRNSAgreement for the sale of Marketing Week
17th Sep 20257:00 amRNSInterim results for the 6 months ended 30 Jun 2025
11th Sep 20257:00 amRNSConditional agreement for the sale of The Lawyer
5th Sep 20252:00 pmRNSHolding(s) in Company
27th Aug 202512:30 pmRNSHolding(s) in Company
19th Aug 20259:39 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
25th Jun 20257:00 amRNSConditional agreement for the sale of MiniMBA
19th Jun 20257:00 amRNSExtension to Exclusivity
22nd May 202512:00 pmRNSDirector/PDMR Shareholding
9th May 20258:16 amRNSResponse to Media Speculation
8th May 202512:33 pmRNSResult of AGM
22nd Apr 202512:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.